Clinical Trial

An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® FX-405 (manufactured by Erchonia Corporation (the Company) in providing a noninvasive adjunctive treatment in combination with periodontal scaling and root planing for improving the treatment of periodontal disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-22; most recent amendment 2026-05-14.
Status change: Not Yet Recruiting → Recruiting 2025-01-29
Trial Details
NCT Number NCT06656325
Lead Sponsor Erchonia Corporation
Conditions Periodontal Diseases, Periodontitis, Gum Disease
Enrollment 70 participants
Start Date 2025-01-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-18